Efficacy of Oral Zinc Supplementation in Radiologically Confirmed Pneumonia: Secondary Analysis of a Randomized Controlled Trial

J Trop Pediatr. 2018 Apr 1;64(2):110-117. doi: 10.1093/tropej/fmx036.

Abstract

Objective: To evaluate the effect of zinc as an adjuvant therapy in radiologically confirmed pneumonia in children 2-24 months of age.

Patients and methods: We analyzed data of 212 children with pneumonia for whom chest X-ray films were available at enrollment and at least two radiologists agreed on the diagnosis of pneumonia. We compared the time to recovery in the two groups (n = 121, zinc group and n = 91, placebo group) using a Cox proportional hazards regression model.

Results: Time to recovery was similar in both groups [median interquartile range: zinc, 84 h (64, 140 h); placebo, 85 h (65, 140 h)]. The absolute risk reduction for treatment failure was 5.2% (95% confidence interval: -4.8, 15.1) with zinc supplementation.

Conclusion: There was no significant beneficial effect of zinc on the duration of recovery or risk of treatment failure in children with radiologically confirmed pneumonia.

Publication types

  • Randomized Controlled Trial
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Dietary Supplements / adverse effects
  • Dietary Supplements / statistics & numerical data
  • Double-Blind Method
  • Female
  • Humans
  • Infant
  • Lung / diagnostic imaging
  • Lung / pathology
  • Male
  • Pneumonia / diagnostic imaging
  • Pneumonia / drug therapy*
  • Proportional Hazards Models
  • Survival Analysis
  • Treatment Outcome
  • Zinc / therapeutic use*

Substances

  • Zinc